Modalis Therapeutics Corporation (JP:4883) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modalis Therapeutics Corporation announces a new executive appointment with Yosuke Nakashima stepping up as VP of Operations and Business Development, after serving as Director of Business Development and US Site Controller.
For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.